RxDoctor Payments Data
★ My doctorsLook up a doctor →

James Strickland

Pulmonary Disease · Birmingham, ALNPI 1548201601

Payments from drug & device makers

$1,427in general payments, 2019–2025

Across 82 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$206
  • GSK$200
  • Philips North America LLC$187
  • Takeda Pharmaceuticals U.S.A., Inc.$180
  • Genentech USA, Inc.$141
  • Mallinckrodt Enterprises LLC$71
  • plus $443 from 15 others

What the payments were for

  • Food & beverage$1,40598%
  • Entertainment$222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca14$206
GSK14$200
Philips North America LLC9$187
Takeda Pharmaceuticals U.S.A., Inc.7$180
Genentech USA, Inc.8$141
Mallinckrodt Enterprises LLC3$71
Boehringer Ingelheim4$65
Insmed, Inc.4$59
Pfizer3$50
Jazz Pharmaceuticals Inc.2$44
Mylan Specialty L.p.2$32
Johnson & Johnson2$26
ANI Pharmaceuticals, Inc.1$25
Cook Medical LLC2$23
Itamar Medical Inc1$22
Mallinckrodt Hospital Products Inc.1$20
Actelion Pharmaceuticals US, Inc.1$18
Merck1$17
AbbVie1$16
Gilead1$16
Cumberland Pharmaceuticals, Inc.1$12

How this compares

$1,427 in reported general payments places this provider in the 35th percentile of 215 pulmonary disease providers in Alabama.

See all pulmonary disease providers in Alabama →

Other pulmonary disease in Birmingham

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →